Recombinant Anti-CD20 x Anti-CD22 Bispecific Antibody (IgG-scFv)
TypeName: Business Offer
Category:
Offer Date:2019/04/18
Country: United States
Summary: Recombinant Anti-CD20 x Anti-CD22 Bispecific Antibody (IgG-scFv) is designed to be expressed as a LC and an extended HC with scFv moiety linked to the C terminus. It is a symmetric bispecific and tetravalent molecule, bivalent for each antigen specificity, 2+2 antigen-binding valency. This BsAb is designed for the research of Lymphoma; Leukemia; Antoimmune disease; Immune dysfunction disease therapy.https://www.creative-biolabs.com/bsab/symbolsearch-cd20%2520%2526%2520cd22.htm
Agriculture & Food
Business Services
Electronics, IT and Telecoms
Leisure & Tourism
Minerals
Textiles, Clothing, Leather,
Transport & Logistics
